Transaction · 0001214659-26-010516

Barber Daniel

Barber Daniel, PRES, reported an open-market or private sale at Aquestive Therapeutics, Inc. involving 25000.000000 shares for an estimated $107167.50. Reported holdings after the transaction were 585574.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SPRES
AQSTAquestive Therapeutics, Inc.
Filing timeAug 18
Trade dateAug 17, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$4.32
Pre-filing
1mo ago -4.6%1w ago -0.7%1d ago -1.6%
Returns since
7d +15.3%30d +21.3%90d +21.3%180d +21.3%1y +21.3%

AQST price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
AQST since 2026-08-18Filed 22 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001214659-26-010516
Common Stock
Transaction date
Aug 17, 2026
Filed Aug 18, 2026, 08:13 PM · 1d delay
Shares
25.0k sh
$429 per share
Estimated value
-$10.7M
Computed from shares × price
Holdings after
585k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The reported transaction involves sale transactions from $4.24 to $4.35 per share. The weighted average price per share was $4.2867. The Reporting Person undertakes to provide upon request by the SEC…

Original filing · 0001214659-26-010516
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

AQST